Providence Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$488K Sell
3,797
-197
-5% -$23.1K 0.28% 33
2026
Q1
$480K Buy
3,994
+152
+4% +$17.5K 0.27% 26
2025
Q4
$404K Sell
3,842
-220
-5% -$20.7K 0.4% 26
2025
Q3
$341K Buy
+4,062
New +$335K 0.33% 32

Other funds holding MRK

Providence Financial Advisors's MRK Position: Q2 2026 in Review

Providence Financial Advisors reduced its Merck (MRK) stake by 4.9% in Q2 2026, selling an estimated $23.1K and leaving 3,797 shares worth $488K. The position accounts for 0.28% of the portfolio, ranked #33.

Providence Financial Advisors first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Providence Financial Advisors held 3,797 shares of Merck worth $488K as of Q2 2026.
  • Providence Financial Advisors sold 197 Merck shares in Q2 2026, an estimated $23.1K.
  • Merck made up 0.28% of Providence Financial Advisors's portfolio in Q2 2026, its #33 holding.
  • Providence Financial Advisors first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Providence Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.